GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Example 3 [WO2010021918]
Compound class:
Synthetic organic
Comment: Veonetinib is the INN for a tyrosine kinase inhibitor from WHO proposed INN list 131 (August 2024). This is a racemic mixture of optical isomers. We show the structure without stereo-specificity to represent the racemate. The structure for veonetinib is claimed as Example 3 in patent WO2010021918 (Advenchen Laboratories) [1]. There is no information in this patent regarding the specific kinase(s) inhibited (just experimental evidence of antiproliferative activity against lung and colon cancer cell lines).
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 5-[2-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxyquinolin-7-yl]oxyethyl]-5-azaspiro[2.4]heptan-7-ol |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13085 | veonetinib |
Synonyms ![]() |
| Example 3 [WO2010021918] |
Database Links ![]() |
|
| CAS Registry No. | 1210828-09-3 (source: WHO INN list) |
| GtoPdb PubChem SID | 500839903 |
| PubChem CID | 46176482 |
| Search Google for chemical match using the InChIKey | RYPUFHJIOUAMKT-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | RYPUFHJIOUAMKT |
| Search PubMed clinical trials | veonetinib |
| Search PubMed titles | veonetinib |
| Search PubMed titles/abstracts | veonetinib |
| UniChem Compound Search for chemical match using the InChIKey | RYPUFHJIOUAMKT-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | RYPUFHJIOUAMKT-UHFFFAOYSA-N |